A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapies
Clinical trial NCT03096834 · COMPLETED
Trial details
- NCT number
- NCT03096834
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-20
- Primary completion
- 2018-01-18
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.